Curative Biotechnology, Inc.
CUBT
$0.0099
$0.000.00%
OTC PK
| 03/31/2025 | 03/31/2024 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 218.30K | -- | 126.90K | 310.20K | 670.30K |
| Total Receivables | -- | -- | -- | -- | 25.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 137.40K | -- | 64.80K | 125.10K | 58.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 355.60K | -- | 191.70K | 435.40K | 753.90K |
|
|
|||||
| Total Current Assets | 355.60K | -- | 191.70K | 435.40K | 753.90K |
| Net Property, Plant & Equipment | 2.10K | -- | 6.50K | 6.60K | 6.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.33M | -- | 1.63M | 1.59M | 1.56M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 600.60K | -- | 204.00K | 161.70K | 93.00K |
| Total Assets | 2.29M | -- | 2.03M | 2.20M | 2.41M |
|
|
|||||
| Total Accounts Payable | 4.17M | -- | 1.35M | 661.70K | 726.90K |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 3.11M | -- | 581.00K | 155.90K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 12.60K | 3.40K | 3.40K |
| Total Other Current Liabilities | -- | -- | 12.60K | 3.40K | 3.40K |
| Total Current Liabilities | 7.28M | -- | 1.95M | 821.10K | 730.30K |
|
|
|||||
| Total Current Liabilities | 7.28M | -- | 1.95M | 821.10K | 730.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 3.11M | -- | 581.00K | 155.90K | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.28M | -- | 1.95M | 821.10K | 730.30K |
|
|
|||||
| Common Stock & APIC | 37.88M | -- | 11.65M | 11.65M | 10.56M |
| Retained Earnings | -42.88M | -- | -29.62M | -28.34M | -26.92M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -5.00M | -- | -17.98M | -16.69M | -16.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 2.60K | -- | 18.07M | 18.07M | 18.04M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 2.60K | -- | 18.07M | 18.07M | 18.04M |
|
|
|||||
| Total Common Equity | -5.00M | -- | -17.98M | -16.69M | -16.36M |
| Total Preferred Equity | 2.60K | -- | 18.07M | 18.07M | 18.04M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.99M | -- | 88.10K | 1.38M | 1.68M |
|
|
|||||